Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-005716
Filing Date
2021-03-05
Accepted
2021-03-05 13:55:55
Documents
1
Period of Report
2021-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6370
  Complete submission text file 0001567619-21-005716.txt   7733
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD., STE. 125 ROCKVILLE MD 20850
Business Address
Peyer James (Reporting) CIK: 0001843594 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 21717827